Keyphrases
Tumor Antigen
100%
Bcl-xL
100%
Anti-apoptotic
100%
In Cancer
33%
Family Protein
33%
Cancer Patients
33%
Anticancer Therapy
16%
Therapeutic Vaccination
16%
Immune Response
16%
Clinical Model
16%
Cellular Immune Response
16%
T-cell Antigen
16%
Cancer Cells
16%
Cancer Immunotherapeutics
16%
Clinical Trials
16%
Cancer-specific
16%
Immunotherapeutic Strategy
16%
Antisense Oligonucleotides
16%
Anticancer Activity
16%
Conventional Therapy
16%
Immune System
16%
Apoptotic Cell Death
16%
Anticancer
16%
Small Molecule Inhibitors
16%
Immunology and Microbiology
Protein Family
100%
Tumor Antigen
100%
Antineoplastic Activity
50%
T Lymphocyte Antigen
50%
Immune System
50%
Cancer Cell
50%
Immunity
50%
Adoptive Immunity
50%
Antisense
50%
Programmed Cell Death
50%
Pharmacology, Toxicology and Pharmaceutical Science
Malignant Neoplasm
100%
Tumor Antigen
100%
Antiapoptotic
100%
T Lymphocyte Antigen
14%
Neoplasm
14%
Antisense Oligonucleotide
14%
Clinical Trial
14%